Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review
<p>Abstract</p> <p>Background</p> <p>Tamoxifen has emerged as a potential management option for gynecomastia and breast pain due to non-steroidal antiandrogens, and it is considered an alternative to surgery or radiotherapy. The objective of this systematic review was t...
Main Authors: | Kunath Frank, Keck Bastian, Antes Gerd, Wullich Bernd, Meerpohl Joerg J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1741-7015/10/96 |
Similar Items
-
THE PROFILE OF TAMOXIFEN USER DUE TO GYNECOMASTIA INDUCED BY ANABOLIC STEROIDS FOR BODYBUILDERS OR BODYBUILDING
by: E. Santos, et al.
Published: (2016-09-01) -
The profile of tamoxifen user due to gynecomastia induced by anabolic steroids for bodybuilders or bodybuilding
by: E. Santos, et al.
Published: (2016-09-01) -
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
by: Weili He, et al.
Published: (2023-03-01) -
Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
by: Emre Yekedüz, et al.
Published: (2021-03-01) -
Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
by: Norman J. Maitland
Published: (2021-01-01)